#fda 2017

FDA approves new treatment Xeljanz (tofacitinib) for moderately to severely active ulcerative colitis

FDA approves new treatment for moderately to severely active ulcerative colitisThe U.S. Food and Drug Administration today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis. Xeljanz is the first oral medication approved for chronic use in this indication. Other FDA-approved treatments for the chronic treatment of…

Abaloparatide, абалопаратид , أبالوباراتيد , 巴罗旁肽 ,

Abaloparatide BA058 BIM-44058 UNII-AVK0I6HY2U BA058; BIM-44058; CAS  247062-33-5 MW 3960.5896, MF C174 H300 N56 O49 абалопаратид [Russian] [INN] أبالوباراتيد [Arabic] [INN] 巴罗旁肽 [Chinese] [INN]

The compound and methods of its synthesis are described in WO 2004/080990, WO 2005/012326 and WO 2007/114475 for example.

The gluconolactone method: In 1988 and 1989 a general method was reported to…

Netarsudil Molecular Formula: C28H27N3O3 Molecular Weight: 453.542 g/mol Netarsudil; UNII-W6I5QDT7QI; W6I5QDT7QI; 1254032-66-0; Netarsudil [USAN]; AR-11324 free base 1422144-42-0 (mesylate)   1254032-66-0 (free base)   1253952-02-1 (HCl) [4-[(2S)-3-amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl]phenyl]methyl 2,4-dimethylbenzoate Netarsudil Mesylate CAS: 1422144-42-0 (mesylate) Chemical Formula:…

Naldemedine Molecular FormulaC32H34N4O6 Average mass570.636 Da CAS 916072-89-4 [RN] CAS Number 1345728-04-2 (tosylate) FDA APPROVED 2017 Morphinan-7-carboxamide, 17-(cyclopropylmethyl)-6,7-didehydro-4,5-epoxy-3,6,14-trihydroxy-N-[1-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]-, (5α)-…

FDA approves treatment for rare genetic enzyme disorder The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs. Continue…

Secnidazole, секнидазол , سيكنيدازول , 塞克硝唑 ,

  Secnidazole Molecular FormulaC7H11N3O3 Average mass185.180 Da 1-(2-Methyl-5-nitroimidazol-1-yl)-2-propanol 1H-Imidazole-1-ethanol, α,2-dimethyl-5-nitro- [ACD/Index Name] 222-134-0 [EINECS] 3366-95-8 [RN] a,2-Dimethyl-5-nitro-1H-imidazole-1-ethanol UNII:R3459K699K секнидазол [Russian] [INN] سيكنيدازول [Arabic] [INN] 塞克硝唑 [Chinese] [INN] RP-14539, PM-185184, Flagentyl Solosec (secnidazole) ;…

FDA approves Mylotarg (gemtuzumab ozogamicin) for treatment of acute myeloid leukemia

FDA approves Mylotarg for treatment of acute myeloid leukemia 09/01/2017 The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML). The FDA also approved Mylotarg for the treatment of patients aged 2 years and older with CD33-positive AML…

FDA approval brings first gene therapy to the United States

FDA approval brings first gene therapy to the United States 08/30/2017 The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases The U.S. Food and Drug Administration issued a historic action today making the first gene…